To examine the role of PDE4 in cardiac hypertrophy and HF, we administered PDE4 inhibitor roflumilast (1 mg/kg/day) or vehicle by oral gavage once daily to mice subjected to chronic ISO (7.5 mg/kg/day) intraperitoneal injection for 1 month. The gene discussed is PDE4A; the disease is cardiac hypertrophy.